{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T16:11:25Z","timestamp":1790179885516,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,4,24]],"date-time":"2020-04-24T00:00:00Z","timestamp":1587686400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,24]],"date-time":"2020-04-24T00:00:00Z","timestamp":1587686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1007\/s00432-020-03213-x","type":"journal-article","created":{"date-parts":[[2020,4,24]],"date-time":"2020-04-24T18:03:46Z","timestamp":1587751426000},"page":"1671-1676","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Selected ellipticine derivatives, known to target topoisomerase II, suppress the alternative lengthening of telomere (ALT) pathway in telomerase\u2013negative cells"],"prefix":"10.1007","volume":"146","author":[{"given":"Sevil","family":"Zencir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Hsun","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel-Sean","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yavuz","family":"Ergun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guan-Ling","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsai-Kun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Chun","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeki","family":"Topcu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,24]]},"reference":[{"key":"3213_CR1","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1128\/EC.05079-11","volume":"10","author":"E Basenko","year":"2011","unstructured":"Basenko E, Topcu Z, McEachern MJ (2011) Recombination can either help maintain very short telomeres or generate longer telomeres via a roll-and-spread mechanism in yeast cells with weak telomerase activity. Eukaryot Cell 10:1131\u20131142","journal-title":"Eukaryot Cell"},{"key":"3213_CR2","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1146\/annurev.bi.61.070192.000553","volume":"61","author":"EH Blackburn","year":"1992","unstructured":"Blackburn EH (1992) Telomerases. Annu Rev Biochem 61:113\u2013129","journal-title":"Annu Rev Biochem"},{"key":"3213_CR3","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1126\/science.aab3389","volume":"350","author":"EH Blackburn","year":"2015","unstructured":"Blackburn EH, Epel ES, Lin J (2015) Human telomere biology: a contributory and interactive factor in aging, disease risks, and protection. Science 350:1193\u20131198","journal-title":"Science"},{"key":"3213_CR100","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1038\/nm1006-1133","volume":"12","author":"EH Blackburn","year":"2006","unstructured":"Blackburn EH, Greider CW, Szostak JW (2006) Telomeres and telomerase: the path from maize, Tetrahymena and yeast to human cancer and aging. Nat Med 12:1133\u20131138","journal-title":"Nat Med"},{"key":"3213_CR4","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1038\/nm1197-1271","volume":"3","author":"TM Bryan","year":"1997","unstructured":"Bryan TM, Englezou A, Dalla-Pozza L, Dunham MA, Reddel RR (1997) Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat Med 3:1271\u20131274","journal-title":"Nat Med"},{"key":"3213_CR5","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/nrg2763","volume":"11","author":"AJ Cesare","year":"2010","unstructured":"Cesare AJ, Reddel RR (2010) Alternative lengthening of telomeres: models, mechanisms and implications. Nat Rev Genet 11:319\u2013330","journal-title":"Nat Rev Genet"},{"key":"3213_CR6","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1007\/s00044-016-1755-z","volume":"26","author":"AM Dar","year":"2017","unstructured":"Dar AM, Uzzaman S, Ahmad MS (2017) Steroidal imidazoles: synthesis, characterization, molecular docking studies with DNA and in vitro cytotoxicity. Med Chem Res 26:2372\u20132383","journal-title":"Med Chem Res"},{"key":"3213_CR7","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/82586","volume":"26","author":"MA Dunham","year":"2000","unstructured":"Dunham MA, Neumann AA, Fasching CL, Reddel RR (2000) Telomere maintenance by recombination in human cells. Nat Genet 26:447\u2013450","journal-title":"Nat Genet"},{"key":"3213_CR8","doi-asserted-by":"publisher","first-page":"4127","DOI":"10.1021\/bi400080t","volume":"52","author":"S Ghosh","year":"2013","unstructured":"Ghosh S, Kar A, Chowdhury S, Dasgupta D (2013) Ellipticine binds to a human telomere sequence: an additional mode of action as a putative anticancer agent? Biochemistry 52:4127\u20134137","journal-title":"Biochemistry"},{"key":"3213_CR9","doi-asserted-by":"publisher","first-page":"3800","DOI":"10.1016\/j.febslet.2010.06.009","volume":"584","author":"JD Henson","year":"2010","unstructured":"Henson JD, Reddel RR (2010) Assaying and investigating alternative lengthening of telomeres activity in human cells and cancers. FEBS Lett 584:3800\u20133811","journal-title":"FEBS Lett"},{"key":"3213_CR10","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/nbt.1587","volume":"27","author":"JD Henson","year":"2009","unstructured":"Henson JD, Cao Y, Huschtscha LI, Chang AC, Au AY, Pickett HA, Reddel RR (2009) DNA C-circles are specific and quantifiable markers of alternative-lengthening-of-telomeres activity. Nat Biotechnol 27:1181\u20131185","journal-title":"Nat Biotechnol"},{"key":"3213_CR11","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.ymeth.2016.08.016","volume":"114","author":"JD Henson","year":"2017","unstructured":"Henson JD, Lau LM, Koch S, Martin La Rotta N, Dagg RA, Reddel RR (2017) The C-circle assay for alternative-lenghtening-of-telomeres activity. Methods 114:74\u201384","journal-title":"Methods"},{"key":"3213_CR12","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1007\/s00018-014-1783-0","volume":"72","author":"MH Hsieh","year":"2015","unstructured":"Hsieh MH, Tsai CH, Lin CC, Li TK, Hung TW, Chang LT, Hsin LW, Teng SC (2015) Topoisomerase II inhibition suppresses the proliferation of telomerase-negative cancers. Cell Mol Life Sci 72:1825\u20131837","journal-title":"Cell Mol Life Sci"},{"key":"3213_CR13","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1038\/cr.2010.95","volume":"20","author":"TH Huang","year":"2010","unstructured":"Huang TH, Chen HC, Chou SM, Yang YC, Fan JR, Li TK (2010) Cellular processing determinants for the activation of damage signals in response to topoisomerase I-linked DNA breakage. Cell Res 20:1060\u20131075","journal-title":"Cell Res"},{"key":"3213_CR14","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1007\/s00044-012-0071-5","volume":"22","author":"AM Isloor","year":"2013","unstructured":"Isloor AM, Sunil D, Prakash Shetty P, Malladi S, Pai KSR, Maliyakkl N (2013) Synthesis, characterization, anticancer, and antioxidant activity of some new thiazolidin-4-ones in MCF-7 cells. Med Chem Res 22:758\u2013767","journal-title":"Med Chem Res"},{"key":"3213_CR15","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/s00044-017-2068-6","volume":"27","author":"T Itoh","year":"2018","unstructured":"Itoh T, Hatae N, Nishiyama T, Choshi T, Hibino S, Yoshimura T, Ishikura M (2018) Synthesis and cytotoxicity of pyrido[4,3-b]carbazole alkaloids against HCT-116 and HL-60 cells. Med Chem Res 27:412\u2013419","journal-title":"Med Chem Res"},{"key":"3213_CR16","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s00044-019-02472-9","volume":"29","author":"AV Kuskucu","year":"2020","unstructured":"Kuskucu AV, Kulm\u00e1ny \u00c1, Erg\u00fcn Y, Zencir S, Zupko I, Durdagi S, Kader S, Zaka M, Orhan H, Topcu Z (2020) Structural modification of ellipticine derivatives with alkyl groups of varying length is influential on their effects on human DNA topoisomerase II: a combined experimental and computational study. Med Chem Res 29:189\u2013198","journal-title":"Med Chem Res"},{"key":"3213_CR17","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/j.bcp.2012.01.025","volume":"83","author":"CH Lee","year":"2012","unstructured":"Lee CH, Hsieh MY, Hsin LW, Chen HC, Lo SC, Fan JR, Chen WR, Chen HW, Chan NL, Li TK (2012) Anthracenedione-methionine conjugates are novel topoisomerase II-targeting anticancer agents with favorable drug resistance profiles. Biochem Pharmacol 83:1208\u20131216","journal-title":"Biochem Pharmacol"},{"key":"3213_CR18","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1002\/fsn3.382","volume":"5","author":"CC Lin","year":"2016","unstructured":"Lin CC, Hsieh MH, Teng SC (2016) Genistein suppresses the proliferation of telomerase-negative cells. Food Sci Nutr 5:197\u2013204","journal-title":"Food Sci Nutr"},{"key":"3213_CR19","first-page":"41","volume":"7","author":"Y Lu","year":"2013","unstructured":"Lu Y, Leong W, Guerin O, Gilson E, Ye J (2013) Telomeric impact of conventional chemotherapy. Front Med 7:41\u2013417","journal-title":"Front Med"},{"key":"3213_CR20","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.tibs.2015.06.003","volume":"40","author":"P Martines","year":"2015","unstructured":"Martines P, Blasco MA (2015) Replicating through telomeres: a means to an end. Trends Biochem Sci 40:504\u2013515","journal-title":"Trends Biochem Sci"},{"key":"3213_CR21","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.mrfmmm.2007.06.009","volume":"623","author":"AK McClendon","year":"2007","unstructured":"McClendon AK, Osheroff N (2007) DNA topoisomerase II, genotoxicity, and cancer. Mut Res 623:83\u201397","journal-title":"Mut Res"},{"key":"3213_CR22","doi-asserted-by":"publisher","first-page":"8883","DOI":"10.1039\/c2ra20584j","volume":"2","author":"CM Miller","year":"2012","unstructured":"Miller CM, McCarthy FO (2012) Isolation, biological activity and synthesis of the natural product ellipticine and related pyridocarbazoles. RSC Adv 2:8883\u20138918","journal-title":"RSC Adv"},{"key":"3213_CR23","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1667\/0033-7587(2001)155[0194:ALOTIH]2.0.CO;2","volume":"155","author":"RR Reddel","year":"2001","unstructured":"Reddel RR, Bryan TM, Colgin LM, Perrem KT, Yeager TR (2001) Alternative lengthening of telomeres in human cells. Radiat Res 155:194\u2013200","journal-title":"Radiat Res"},{"key":"3213_CR24","first-page":"381","volume":"6","author":"BB Sarikaya","year":"2012","unstructured":"Sarikaya BB, Zencir S, Somer NU, Kaya GI, Onur MA, Bastida J, Zupko I, Topcu Z (2012) The effects of arolycoricidine and narciprimine on tumor cell killing and topoisomerase activity. Rec Nat Prod 6:381\u2013385","journal-title":"Rec Nat Prod"},{"key":"3213_CR25","doi-asserted-by":"publisher","first-page":"20","DOI":"10.2174\/1874104501206010020","volume":"6","author":"MF Sassano","year":"2012","unstructured":"Sassano MF, Schlesinger AP, Jarstfer MB (2012) Identification of G quadruplex inducers using a simple, inexpensive and rapid high throughput assay, and their inhibition of human telomerase. Open Med Chem J 6:20\u201328","journal-title":"Open Med Chem J"},{"key":"3213_CR26","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1126\/science.1222394","volume":"336","author":"JW Shay","year":"2012","unstructured":"Shay JW, Reddel RR, Wright WE (2012) Cancer and telomeres\u2013an ALTernative to telomerase. Science 336:1388\u20131390","journal-title":"Science"},{"key":"3213_CR27","doi-asserted-by":"publisher","first-page":"575","DOI":"10.2174\/09298673113206660272","volume":"21","author":"M Stiborova","year":"2014","unstructured":"Stiborova M, Frei E (2014) Ellipticines as DNA-targeted chemotherapeutics. Curr Med Chem 21:575\u2013591","journal-title":"Curr Med Chem"},{"key":"3213_CR28","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/S1097-2765(05)00094-8","volume":"6","author":"SC Teng","year":"2000","unstructured":"Teng SC, Chang J, McCowan B, Zakian VA (2000) Telomerase independent lengthening of yeast telomeres occurs by an abrupt Rad50p-dependent, Rif-inhibited recombinational process. Mol Cell 6:947\u2013952","journal-title":"Mol Cell"},{"key":"3213_CR29","doi-asserted-by":"publisher","first-page":"3348","DOI":"10.1073\/pnas.0408770102","volume":"102","author":"Z Topcu","year":"2005","unstructured":"Topcu Z, Nickles K, Davis C, McEachern M (2005) Abrupt disruption of capping and a single source for recombinationally elongated telomeres in K. Lactis Proc Natl Acad Sci 102:3348\u20133353","journal-title":"Lactis Proc Natl Acad Sci"},{"key":"3213_CR30","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1016\/j.bmcl.2016.02.034","volume":"26","author":"KR Vann","year":"2016","unstructured":"Vann KR, Ergun Y, Zencir S, Oncuoglu S, Osheroff N, Topcu Z (2016) Inhibition of human DNA topoisomerase II\u03b1 by two novel ellipticine derivatives. Bioorganic Med Chem Lett 26:1809\u20131812","journal-title":"Bioorganic Med Chem Lett"},{"key":"3213_CR31","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1146\/annurev.bi.65.070196.003223","volume":"65","author":"JC Wang","year":"1996","unstructured":"Wang JC (1996) DNA topoisomerases. Annu Rev Biochem 65:635\u2013692","journal-title":"Annu Rev Biochem"},{"key":"3213_CR32","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1177\/002215540305100703","volume":"51","author":"S Yasuhara","year":"2003","unstructured":"Yasuhara S, Zhu Y, Matsui T, Tipirneni N, Yasuhara Y, Kaneki M, Rosenzweig A, Martyn JAJ (2003) Comparison of comet assay, electron microscopy, and flow cytometry for detection of apoptosis. J Histochem Cytochem 51:873\u2013885","journal-title":"J Histochem Cytochem"},{"key":"3213_CR33","first-page":"4175","volume":"59","author":"TR Yeager","year":"1999","unstructured":"Yeager TR, Neumann AA, Englezou A, Huschtscha LI, Noble JR, Reddel RR (1999) Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body. Cancer Res 59:4175\u20134179","journal-title":"Cancer Res"},{"key":"3213_CR34","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.tiv.2006.01.004","volume":"20","author":"Y Yu","year":"2006","unstructured":"Yu Y, Zhu W, Diao H, Zhou C, Chen FF, Yang J (2006) A comparative study of using comet assay and \u03b3H2AX foci formation in the detection of N-methyl-N\u2032-nitro-N-nitrosoguanidine-induced DNA damage. Toxicol In Vitro 20:959\u2013965","journal-title":"Toxicol In Vitro"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-020-03213-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-020-03213-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-020-03213-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,25]],"date-time":"2021-04-25T05:29:52Z","timestamp":1619328592000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-020-03213-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,24]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["3213"],"URL":"https:\/\/doi.org\/10.1007\/s00432-020-03213-x","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,24]]},"assertion":[{"value":"6 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing financial and non-financial interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}